Latest Articles

Open Access
SPOCD1 Enhances Cancer Cell Activities and Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma
TUVSHIN BAYASGALAN, MITSURO KANDA, YUSUKE SATO, HAOTE ZHU, MOHAMMAD HUSSAIN HAMRAH, FLOR ESTHER GARZA MARTINEZ, TAKAHIRO SHINOZUKA, YUKI ITO, MASAHIRO SASAHARA, DAI SHIMIZU, SHINICHI UMEDA, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, CHIE TANAKA and YASUHIRO KODERA

Cancer Genomics & Proteomics March 2025, 22 (2) 306-325; DOI: https://doi.org/10.21873/cgp.20503
Open Access
Methylation of ESRα Promoters in Benign Breast Tumors Could Be a Signature for Progression to Breast Cancer in African American Women
SYLVIA DASI, TAMMEY J. NAAB, BERNARD KWABI-ADDO, VICTOR APPREY, DESTA BEYENE, ROBERT L. DEWITTY, STEVEN NAGEL, ROBIN WILLIAMS, KELLY BOLDEN, ANDREA HAYES-DIXON, BABAK SHOKRANI, DELISHA A. STEWART, OLAKUNLE O. KASSIM, ROBERT L. COPELAND and YASMINE M. KANAAN

Cancer Genomics & Proteomics March 2025, 22 (2) 208-230; DOI: https://doi.org/10.21873/cgp.20497
Open Access
Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk
CHIH-CHIANG HUNG, YUN-CHI WANG, HOU-YU SHIH, CHIA-HUA LIU, JIE-LONG HE, JAW-CHYUN CHEN, WEN-SHIN CHANG, CHEN-HSIEN SU, DA-TIAN BAU and CHIA-WEN TSAI

Cancer Genomics & Proteomics March 2025, 22 (2) 258-270; DOI: https://doi.org/10.21873/cgp.20500
Open Access
Clinical Characteristics and Chemosensitivity in Germline TP53 Pathogenic Variant Cases Identified by Cancer Genomic Testing
YOSUKE SAITO, YUKI HOSHI, MASAMICHI SATO, MANABU SEINO, NORIKAZU WATANABE, MASAAKI KAWAI and SHUHEI SUZUKI

Cancer Genomics & Proteomics March 2025, 22 (2) 354-362; DOI: https://doi.org/10.21873/cgp.20506
Open Access
Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression
HEE YUN, GWAN HEE HAN, DANIEL J. WEE, DOO-BYUNG CHAY, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO

Cancer Genomics & Proteomics March 2025, 22 (2) 271-284; DOI: https://doi.org/10.21873/cgp.20501
Open Access
Characterization of the Genomic Landscape in HPV-positive Cervical and Head and Neck Squamous Cell Carcinomas by Whole Genome Next Generation Sequencing
JIANLAN REN, NIAN MA, TYLER SECKAR, SHEYNAZ BASSA, NICOLA ZETOLA, SURBHI GROVER, ZHI WEI and ERLE ROBERTSON

Cancer Genomics & Proteomics March 2025, 22 (2) 188-207; DOI: https://doi.org/10.21873/cgp.20496
Open Access
Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders
MARIA PAGONI, VASILEIOS L. ZOGOPOULOS, STAVROS KONTOGIANNIS, ANNIA TSOLAKOU, VASSILIOS ZOUMPOURLIS, GEORGE TH. TSANGARIS, ELEFTHERIOS FOKAEFS, IOANNIS MICHALOPOULOS, ARISTIDIS M. TSATSAKIS and NIKOLAOS DRAKOULIS

Cancer Genomics & Proteomics March 2025, 22 (2) 285-305; DOI: https://doi.org/10.21873/cgp.20502
Open Access
Engineered Methioninase-expressing Tumor-targeting Salmonella typhimurium A1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine
YUTARO KUBOTA, MING ZHAO, QINGHONG HAN, YUSUKE AOKI, NORIYUKI MASAKI, KOYA OBARA, SEI MORINAGA, KOHEI MIZUTA, MOTOKAZU SATO, MICHAEL BOUVET, KOICHI KUBOTA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

Cancer Genomics & Proteomics March 2025, 22 (2) 247-257; DOI: https://doi.org/10.21873/cgp.20499
Open Access
Prostate Cancer: De-regulated Circular RNAs With Efficacy in Preclinical In Vivo Models
ULRICH H. WEIDLE and FABIAN BIRZELE

Cancer Genomics & Proteomics March 2025, 22 (2) 136-165; DOI: https://doi.org/10.21873/cgp.20494
Open Access
DEFA1, Primarily Expressed at the Invasive Tumor Front, Promotes OSCC Cell Invasion and Tumor Growth
HOJIN JEONG, SANG WOONG PARK and YOUNG SUN HWANG

Cancer Genomics & Proteomics March 2025, 22 (2) 326-345; DOI: https://doi.org/10.21873/cgp.20504

Main menu

User menu

Search

Latest Articles

Pages